tm logo
XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT
Live/Registered
REGISTERED

on 26 Mar 2024

Last Applicant/ Owned by

88471 Laupheim

DE

Serial Number

79362259 filed on 23rd May 2022

Registration Number

7334071 registered on 26th Mar 2024

in the Principal Register

Correspondent Address

Walter Hill Levie III

MEUNIER CARLIN & CURFMAN LLC

999 Peachtree Street NE

Suite 1300

Atlanta,GA 30309

Filing Basis

1. filing basis filed as 66 a

Disclaimer

"EXPERT ALLIANCE"

XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT

Scientific and technological services, namely, scientific research, analysis, testing and development in the field of biomanufacturing and in the pharmaceutical field and research and design relating thereto; industrial analysis and research services, namely, chemical, biochemical, biological and bacteriological research and analysis and industrial research in the field of pharmaceuticals; chemist Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services; medical assistance; animal healthcare services, namely, animal breeding, animal grooming, medical analysis services for diagnostic and treatment purposes; consultancy and information services relating to biopharmaceutical products, namely, providing medical information and pharmaceutical consultation in the nature of a medical consultation relating to biopharmaceutical products

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services, namely, scientific research, analysis, testing and development in the field of biomanufacturing and in the pharmaceutical field and research and design relating thereto; industrial analysis and research services, namely, chemical, biochemical, biological and bacteriological research and analysis and industrial research in the field of pharmaceuticals; chemistry services, namely, chemistry consultation, research in the fields of chemistry; biochemical services, namely, biochemistry consultation, research in the fields of biochemistry; services of medical, bacteriological and chemical laboratories, namely, laboratory research and laboratory analysis; research on the subject of pharmaceuticals; biochemistry research services; development of pharmaceutical, veterinary and diagnostic products and substances and methods for the manufacture thereof, in particular using biotechnological and genetically-engineered means, in the nature of research in the field of manufacturing machinery for pharmaceutical, veterinary and diagnostic products and substances, design and development of computer hardware for the pharmaceutical, veterinary and diagnostic products and substances manufacturing industries; technological consultancy relating to pharmacy, namely, consulting services in the field of pharmaceutical research and development, technical consulting in the field of pharmaceutical studies; technological consultancy in the veterinary research field; technological consultancy in the field of diagnostics, namely, consulting services in the field of pharmaceutical research and development, consulting services in the field of pharmacogenetics; quality control for others; providing information and data relating to medical research and development; development of syringes and instruments for injections, injectors and packaging for the aforesaid goods for others; product quality and product safety testing, namely, chemical testing, physical testing and process engineering testing, in particular laboratory testing; pharmacological and microbiological development, research and analysis for others; conducting clinical tests, namely, scientific research in the nature of conducting clinical trials for others; conducting technical project studies in the nature of scientific feasibility studies and technological support services being technological research in the field of pharmaceutical agent manufacturing processes and pharmaceutical co-filling and packaging processes; industrial manufacturing process development consultancy

Class [040]
Treatment & Processing of Materials Services


Contract manufacturing in the field of pharmaceuticals and pharmaceutical substances; custom manufacture of veterinary preparations and substances; custom manufacture of diagnostic preparations and substances for medical and veterinary use; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; consultancy services relating to custom manufacturing process services; assembly of products for others, custom manufacture and assembly services, custom assembly for others of electronic components for medical devices and apparatus, semiconductor components and circuit switches; consultancy and information for the customised manufacture and production processes for electronic components, semi-conductor components and circuits for medical apparatus and equipment

Class [039]
Transportation & Storage Services


Bottling services and storage of goods in the nature of liquid and solid substances, especially, pharmaceuticals, medicines and solutions, for others

Mark Details


Serial Number

No 79362259

Mark Type

No Service Mark

Attorney Docket Number

No 10593-930US1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

26.05.13 -

Two Triangles

26.05.21 -

Triangles that are completely or partially shaded

Description of Design Search

The mark consists of the stacked wording "XPERT ALLIANCE" in blue. To the right of the term "XPERT" appears the wording "RENTSCHLER" in orange above the wording "& VETTER" in orange. All the aforesaid appears above the wording "SUBSTANCE PRODUCT PATIENT" in black with these terms separated by orange triangles.

Legal History


Show more

Status DateAction Taken
26th Mar 2024REGISTERED-PRINCIPAL REGISTER
26th Mar 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
09th Jan 2024PUBLISHED FOR OPPOSITION
09th Jan 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08th Jan 2024NOTIFICATION PROCESSED BY IB
20th Dec 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20th Dec 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
20th Dec 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05th Dec 2023EXAMINERS AMENDMENT -WRITTEN
05th Dec 2023EXAMINERS AMENDMENT E-MAILED